1. Home
  2. MRNA vs CI Comparison

MRNA vs CI Comparison

Compare MRNA & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$255.93

Market Cap

91.2B

Sector

Health Care

ML Signal

N/A

Logo The Cigna Group

CI

The Cigna Group

N/A

Current Price

$293.97

Market Cap

78.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRNA
CI
Founded
2010
1792
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.2B
78.8B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
MRNA
CI
Price
$255.93
$293.97
Analyst Decision
Hold
Buy
Analyst Count
23
24
Target Price
$138.37
★ $342.29
AVG Volume (30 Days)
★ 16.5M
1.4M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
★ 2.07%
EPS Growth
21.77
★ 83.00
EPS
N/A
★ 18.02
Revenue
$19,263,000,000.00
★ $274,900,000,000.00
Revenue This Year
$8.13
$4.56
Revenue Next Year
$16.26
$4.08
P/E Ratio
★ N/A
$24.34
Revenue Growth
4.29
★ 11.24
52 Week Low
$22.28
$256.52
52 Week High
$258.72
$316.27

Technical Indicators

Market Signals
Indicator
MRNA
CI
Relative Strength Index (RSI) 65.39 50.43
Support Level $45.39 $274.30
Resistance Level N/A $304.49
Average True Range (ATR) 23.10 7.89
MACD 1.95 -1.10
Stochastic Oscillator 94.48 10.36

Price Performance

Historical Comparison
MRNA
CI

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CI The Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

Share on Social Networks: